Page 3 of Glenmark Pharmaceuticals

According to the company’s press statement, the generic version of Onglyza Tablets, 2.5 mg and 5 mg, of AstraZeneca AB.

According to IQVIA TM sales data for the 12-month period ending January 2023, the Compazine Tablets, 5 mg and 10…

GRC 54276 is an orally available, small-molecule hematopoietic progenitor kinase 1 (HPK1) inhibitor developed by Glenmark.

According to IQVIATM sales data for the 12-month period ending January 2023, the Cleocin Hydrochloride Capsules, 75 mg, 150 mg,…

According to a press statement, Glenmark expects to commence distribution of the product in the U.S. during the second half…

Meanwhile, consolidated profit before tax jumped 37.3% to Rs 471 crore in Q3 FY23 from Rs 343.04 crore in Q3…

The drug is already being marketed in the EU, the US, and Australia.

Bumetanide is used to reduce extra fluid in the body (edema) caused by conditions such as congestive heart failure, liver…

Earlier this year, Glenmark also launched Sitagliptin (Sitazit) and its FDCs, followed by Lobeglitazone (LOBG) and FDCs of Teneligliptin including…